Article

Wachira Joins US Pharmacopeia

Catherine Wachira has joined The US Pharmacopeia (USP, www.usp.org), as director of the Drug Quality and Information (DQI) program.

Catherine Wachira has joined The US Pharmacopeia (USP, www.usp.org), as director of the Drug Quality and Information (DQI) program. USP’s DQI program provides assistance in drug quality assurance, develops and disseminates drug and therapeutic information, trains laboratory staff, and provides scientific evidence for healthcare decision-making in developing countries. Wachira previously served as director of clinical research for Callisto Pharmaceuticals.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
© 2025 MJH Life Sciences

All rights reserved.